Lung Injury Global Clinical Trials Review, H2, 2017

GlobalData
106 Pages - GLDATA63007

$2,500.00

Summary

GlobalData's clinical trial report, “Lung Injury Global Clinical Trials Review, H2, 2017" provides an overview of Lung Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Lung Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies Mentioned

GlaxoSmithKline Plc
THERAMetrics holding AG
Silence Therapeutics Plc
Merck & Co Inc
Menemsha Pharmaceuticals Ltd
Ivy Institute of Stem Cells Co Ltd
F. Hoffmann-La Roche Ltd
Eli Lilly and Co
Asklepion Pharmaceuticals LLC
Altor BioScience Corp

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Lung Injury to Respiratory Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Lung Injury to Respiratory Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Lung Injury Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profile Snapshots 29
Appendix 104
Abbreviations 104
Definitions 104
Research Methodology 105
Secondary Research 105
About GlobalData 106
Contact Us 106
Source 106

List of Tables
Lung Injury Therapeutics, Global, Clinical Trials by Region, 2017* 6
Lung Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Lung Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Lung Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 9
Lung Injury Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
Lung Injury Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
Lung Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 12
Lung Injury Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 13
Proportion of Lung Injury to Respiratory Clinical Trials, G7 Countries (%), 2017* 14
Lung Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Lung Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Lung Injury to Respiratory Clinical Trials, E7 Countries (%), 2017* 17
Lung Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
Lung Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
Lung Injury Therapeutics, Global, Clinical Trials by Phase, 2017* 20
Lung Injury Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 21
Lung Injury Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
Lung Injury Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
Lung Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
Lung Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 25
Lung Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
Lung Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
Lung Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28

List of Figures
Lung Injury Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Lung Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Lung Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Lung Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 9
Lung Injury Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
Lung Injury Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
Lung Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 12
Proportion of Lung Injury to Respiratory Clinical Trials, G7 Countries (%), 2017* 14
Lung Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Lung Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Lung Injury to Respiratory Clinical Trials, E7 Countries (%), 2017* 17
Lung Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
Lung Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
Lung Injury Therapeutics, Global, Clinical Trials by Phase (%), 2017* 20
Lung Injury Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 21
Lung Injury Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
Lung Injury Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
Lung Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
Lung Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 25
Lung Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
Lung Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
Lung Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28
GlobalData Methodology 105

Local PDF $2,500.00
Global PDF $7,500.00

$2,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

Custom Research

[email protected]
+1 212 564 2838

Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838